Trillium Therapeutics

YTD

ALL

Why Robinhood?

You can watch TRIL and buy or sell other stocks, ETFs, and their options commission-free!

About TRIL

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation.

CEO

Jan Skvarka, PhD, MBA

CEOJan Skvarka, PhD, MBA

Employees

—

Employees—

Headquarters

Mississauga, Ontario

HeadquartersMississauga, Ontario

Founded

2004

Founded2004

Employees

—

Employees—

TRIL Key Statistics

Market cap

1.64B

Market cap1.64B

Price-Earnings ratio

74.87

Price-Earnings ratio74.87

Dividend yield

—

Dividend yield—

Average volume

3.67M

Average volume3.67M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$20.96

52 Week high$20.96

52 Week low

$5.80

52 Week low$5.80

People also own

Based on the portfolios of people who own TRIL. This list is generated using Robinhood data, and it’s not a recommendation.